| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |